|
|
|
|
Healthy Sex Life After A Cardiac Event
Resuming sexual activity is expressed by patients as extremely important after a myocardial infarction (MI).In spite of this, sex counselling is an area of nursing practice that is frequently neglected and needs more evidence-based...
|
|
|
Baby steps: Laser therapy resolves infantile hemangiomas in many cases
Treating infantile hemangiomas with lasers Avoiding complications from hemangiomas Accessibility of laser therapy for patients with infantile hemangiomas The first cutaneous use for lasers was on vascular lesions in the 1970s.Since that...
|
|
|
RNA interference-mediated downregulation of Beclin1 attenuates cerebral ischemic injury in rats
To test the role of the Beclin 1-dependent autophagy pathway in brain damage during cerebral ischemia.Methods: Focal cerebral ischemia was established in rats using a middle cerebral artery occlusion (MCAO) model. A lentiviral...
|
|
|
Dedicated pharma hub planned for Total Processing & Packaging
Skip to [ Story Content and jump story attachments ] Printable version E-mail to a friend External weblinks Manufacturing Chemist is not responsible for the content of external internet sites.- - - - - - - Main Page Content: The dedicated...
|
|
|
Acute Stroke Diagnosis
Yew KS et al.- Stroke can be categorized as ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Awakening with or experiencing the abrupt onset of focal neurologic deficits is the hallmark of ischemic stroke...
|
|
|
Target Antigen Identified for Common Kidney Disease
CLEVELAND, July 2 -- A newly identified target antigen -- M-type phospholipase A2 receptor or PLA2R -- may hold the key to both diagnosis and treatment of idiopathic membranous nephropathy, according to a multinational team of researchers.
|
|
|
Neurodegenerative Disease Therapy: Researchers from University of California, Department of Neurology detail n
Researchers from University of California, Department of Neurology detail new studies and findings in the area of neurodegenerative disease therapy Researchers detail in 'Functional genomic analysis of frataxin deficiency reveals tissue...
|
|
|
Protein kinase A-dependent suppression of reactive oxygen species in transient focal ischemia in adrenomedulli
1Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan 2Department of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan 3Department of Clinical Laboratory Medicine, Faculty of Medicine, University of Tokyo...
|
|
|
Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia
You can also purchase online an Individual or Institutional Subscription to this journal or buy one or more printed volumes.Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral...
|
|
|
Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion
Focal adhesion kinase (FAK) is overexpressed in a variety of cancers, such as breast, colon, prostate, ovary, and lung cancers.However, the mechanism by which extracellular matrix fibronectin stimulates lung cancer cell migration...
|
|
|
Prevalence of primary focal or segmental dystonia in adults in the district of Foggia, Southern Italy: A servi
; age 18-34 yrs: 39.2; 35-54 yrs: 98.7; 55-74 yrs: 273.6; 75+ yrs: 163.3 Standardized rate: 137.5 Blepharospasm most common clinical condition (prevalence 68.Prevalence of primary focal or segmental dystonia in adults in the...
|
|
|
San Francisco aims for universal coverage
Manny Crisostomo / mcrisostomo@sacbee.com San Francisco Mayor Gavin Newsom envisions a statewide network of community clinics but admits few counties have the infrastructure, including clinics, that San Francisco had in place.Manny...
|
|
|
Size selective behavior of mesenchymal stem cells on ZrO2 and TiO2 nanotube arrays
Article citation: Sebastian Bauer, Integr.Biol., 2009, DOI: 10.1039/b908196h Sebastian Bauer, Jung Park, Josef Faltenbacher, Steffen Berger, Klaus von der Mark and Patrik Schmuki This work reports on the behavior of mesenchymal stem cells...
|
|
|
Detection and characterization of focal hepatic lesions by T2-weighted imaging: comparison of navigator-trigge
Langford Lane, Kidlington Oxford.OX5 1GB UK Tel: +44 (0) 1865-843177 (Within Europe) Fax: +44 (0) 1865-843970 E-mail: eurosupport@elsevier.com North American and Rest of World Online Customer Service 6277 Sea Harbor Drive Orlando.
|
|
|
Cataract surgery: Phacoemulsification fluidics characterized by new lab methods
The analyses were performed using a technique called particle image velocimetry, which is based on tracking the displacement of neutrally buoyant, micrometer-sized glass spheres in a bi-dimensional space.Findings indicate that torsional...
|
|
|
Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells diss
This response is attributable to the cells' inability to trigger adhesion-related signaling events when they are scattered sparsely within the extracellular matrix (ECM) of the parenchyma.This situation is recapitulated by culturing these...
|
|
|
ThromboGenics' Microplasmin Phase III Program Progressing According To Schedule
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its lead product microplasmin, which is in...
|
|
|
Misonix Announces Participation in 2nd International Workshop on Focal Therapy
FARMINGDALE, N.Y., June 25 /PRNewswire-FirstCall/ --Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions,...
|
|
|
Misonix Announces Participation in 2nd International Workshop on Focal Therapy
FARMINGDALE, N.Y., June 25 /PRNewswire-FirstCall/ --Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions,...
|
|
|
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
LEUVEN, Belgium, June 25 /PRNewswire-FirstCall/ -- - Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV Microplasmin's Phase III program is...
|
|
|
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
- Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development...
|
|
|
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
LEUVEN, Belgium, June 25 /PRNewswire-FirstCall/ -- - Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV , a biotechnology company focused on the...
|
|
|
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
- Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV , a biotechnology company focused on the discovery and development of innovative treatments...
|
|
|
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
- Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV , a biotechnology company focused on the discovery and development of innovative treatments...
|
|
|
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
Enter Symbols: Sponsored by: LEUVEN, Belgium, June 25 /PRNewswire-FirstCall/ -- - Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV , a...
|
